Which document must manufacturers regularly submit to regulatory authorities summarizing accumulated post-marketing safety data on an approved drug?
Show answer and explanation
Correct answer: Periodic safety update report
A Periodic Safety Update Report (PSUR) provides updated safety data on marketed drugs. It includes information on new adverse events and risk-benefit evaluations over time.
Keep practicing
More Pharmacovigilance questions
- Which pharmacovigilance method is widely acknowledged to capture only a fraction of all drug-related adverse events that actually occur?
- Which pharmacovigilance term encompasses any undesirable clinical occurrence following drug exposure, regardless of whether the drug caused…
- Which population is often underrepresented in pre-marketing clinical trials?
- Risk management plans in pharmacovigilance are designed to:
- Which study design is particularly useful for investigating rare adverse drug reactions?
- Black box warnings are issued to: